The Diogenix buy was 11 million? Lympro I thought was 7 million could be wrong, but you are disregarding all the money spent on advancing Lympro. Icon labs, multiple AAIC posters, 50k silver sponsorship, Ravi Karons pay, etc. You have to take into account all the expenses of years of Lympro advancement. Every hotel, plane ticket its all part of the costs. We have spent millions in diluted shares on Lympro. So even at a sale cost of 2 million you are looking closer to 7 in cost by now. Yes it would be embarrassing to sell for loss at 15 million.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links